XORTX Therapeutics (XRTX) Total Current Liabilities (2020 - 2024)

XORTX Therapeutics' (XRTX) quarterly Total Current Liabilities came in at $340928.0 in Q1 2024, up 15.59% on a QoQ basis from $294938.0 in Q4 2023.

XORTX Therapeutics (XRTX) Total Current Liabilities (2020 - 2024) Analysis & Trends

XORTX Therapeutics (XRTX) has 5 years of Total Current Liabilities data on file, last reported at $340928.0 in Q1 2024.

Quarterly Total Current Liabilities changed N/A year-over-year to $340928.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $340928.0 (changed N/A YoY) and the FY2023 annual result came in at $294938.0, down 80.48% from the prior year.
Total Current Liabilities climbed to $340928.0 in Q1 2024, from $294938.0 in the prior quarter.
In the past five years, Total Current Liabilities ranged from a high of $1.5 million in Q4 2022 to a low of $294938.0 in Q4 2023.
A 5-year average of $636106.4 and a median of $553757.0 in 2023 frame the typical range for Total Current Liabilities.
Annual changes were most pronounced in 2022 — Total Current Liabilities soared 171.6% — and 2023, when it plunged 80.47%.
Tracing XRTX's Total Current Liabilities over 5 years: stood at $793297.9 in 2020, then declined by 29.9% to $556127.8 in 2021, then soared by 171.6% to $1.5 million in 2022, then sank by 80.47% to $294938.0 in 2023, then advanced by 15.59% to $340928.0 in 2024.
The last three Total Current Liabilities figures came in at $340928.0 (Q1 2024), $294938.0 (Q4 2023), and $553757.0 (Q3 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Current Liabilities (Qtr)
1	Vertex Pharmaceuticals	139.61 Bn	131.75 Bn	2.84 Bn	3.94 Bn
2	Regeneron Pharmaceuticals	86.70 Bn	78.71 Bn	3.93 Bn	5.53 Bn
3	Argenx Se	65.28 Bn	60.09 Bn	1.37 Bn	1.58 Bn
4	Moderna	59.14 Bn	54.00 Bn	52.00 Mn	2.53 Bn
5	BeOne Medicines	42.13 Bn	37.03 Bn	1.53 Bn	2.12 Bn
6	Alnylam Pharmaceuticals	31.83 Bn	28.52 Bn	992.69 Mn	1.51 Bn
7	BioNTech SE	28.07 Bn	9.68 Bn	668.28 Mn	2.49 Bn
8	Insmed	27.54 Bn	26.38 Bn	358.27 Mn	438.74 Mn
9	Royalty Pharma	27.31 Bn	26.47 Bn	-	630.93 Mn
10	XORTX Therapeutics	2.84 Mn	2.84 Mn	-	-

Download Data